text:
Andrew Willan
Professor Emeritus, Health Research Methods, Evidence, and Impact
EMAIL: willana
EMAIL: andy
Faculty of Health Sciences, McMaster University
Professor Emeritus, Health Research Methods, Evidence, and Impact, Faculty of Health Sciences
Scholarly Activity in McMaster Experts
selected scholarly activity
Coached, Coordinated, Enhanced Neonatal Transition (CCENT): protocol for a multicentre pragmatic randomised controlled trial of transition-to-home support for parents of high-risk infants. BMJ Open. 11:e046706-e046706. 2021
Intermittent vs Continuous Pulse Oximetry in Hospitalized Infants With Stabilized Bronchiolitis. Archives of Pediatrics and Adolescent Medicine. 175:466-466. 2021
Planned Cesarean or planned vaginal delivery for twins: secondary analysis of randomized controlled trial. Ultrasound in Obstetrics and Gynecology. 57:582-591. 2021
A randomized trial evaluating virus-specific effects of a combination probiotic in children with acute gastroenteritis. Nature Communications. 11:2533. 2020
A suicide prevention strategy for youth presenting to the emergency department with suicide related behaviour: protocol for a randomized controlled trial. BMC Psychiatry. 20:20. 2020
Non-steroidal or opioid analgesia use for children with musculoskeletal injuries (the No OUCH study): statistical analysis plan. Current Controlled Trials in Cardiovascular Medicine Trials. 21:759. 2020
Recruitment of adolescents with suicidal ideation in the emergency department: lessons from a randomized controlled pilot trial of a youth suicide prevention intervention. BMC Medical Research Methodology. 20:231. 2020
Bayesian methods for pilot studies. Clinical Trials. 17:414-419. 2020
Study protocol for two complementary trials of non-steroidal or opioid analgesia use for children aged 6 to 17 years with musculoskeletal injuries (the No OUCH study). BMJ Open. 10:e035177-e035177. 2020
Complex care for kids Ontario: protocol for a mixed-methods randomised controlled trial of a population-level care coordination initiative for children with medical complexity. BMJ Open. 9:e028121-e028121. 2019
Planned cesarean or vaginal delivery for women in spontaneous labor with a twin pregnancy: A secondary analysis of the Twin Birth Study. Birth. 46:193-200. 2019
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Obstetrical and Gynecological Survey. 74:1-2. 2019
The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. BMC Pediatrics. 18:85. 2018
Urinary stress incontinence and other maternal outcomes 2 years after caesarean or vaginal birth for twin pregnancy: a multicentre randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology. 125:1682-1690. 2018
Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis. New England Journal of Medicine. 379:2015-2026. 2018
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. New England Journal of Medicine. 379:535-546. 2018
Mortality After Pediatric Arterial Ischemic Stroke. Pediatrics. 141. 2018
Intermittent versus continuous oxygen saturation monitoring for infants hospitalised with bronchiolitis: study protocol for a pragmatic randomised controlled trial.. BMJ Open. 8:e022707. 2018
Effect of a Pediatric Early Warning System on All-Cause Mortality in Hospitalized Pediatric Patients. JAMA - Journal of the American Medical Association. 319:1002-1002. 2018
Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size. Medical Decision Making. 38:26-33. 2018
The effect of induction method in twin pregnancies: a secondary analysis for the twin birth study. BMC Pregnancy and Childbirth. 17:9. 2017
The impact of pedestrian countdown signals on single and two vehicle motor vehicle collisions: a quasi-experimental study. Injury control and safety promotion International Journal of Injury Control and Safety Promotion. 24:429-434. 2017
Appendectomy versus non-operative treatment for acute uncomplicated appendicitis in children: study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial. BMJ Paediatrics Open. 1. 2017
Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments. Medical Decision Making. 37:262-272. 2017
Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trial. BMJ Open. 7:e014080-e014080. 2017
Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation study. Current Controlled Trials in Cardiovascular Medicine Trials. 17:310. 2016
Magnesium nebulization utilization in management of pediatric asthma (MagNUM PA) trial: study protocol for a randomized controlled trial. Current Controlled Trials in Cardiovascular Medicine Trials. 17:261. 2016
Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis. JAMA - Journal of the American Medical Association. 315:1966-1966. 2016
Expected Value of Sample Information with Imperfect Implementation. Medical Decision Making. 36:282-283. 2016
Re: Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology. 123:644-644. 2016
Twin Birth Study: 2-year neurodevelopmental follow-up of the randomized trial of planned cesarean or planned vaginal delivery for twin pregnancy. American Journal of Obstetrics and Gynecology. 214:371.e1-371.e19. 2016
Evaluating processes of care and outcomes of children in hospital (EPOCH): study protocol for a randomized controlled trial. Current Controlled Trials in Cardiovascular Medicine Trials. 16:245. 2015
Maternal vitamin D supplementation during pregnancy and lactation to promote infant growth in Dhaka, Bangladesh (MDIG trial): study protocol for a randomized controlled trial. Current Controlled Trials in Cardiovascular Medicine Trials. 16:300. 2015
Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments. Annals of Emergency Medicine. 66:455-463.e4. 2015
Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology. 122:1653-1662. 2015
Emergency Department Treatment of Children With Diarrhea Who Attend Day Care. Clinical Pediatrics. 54:1158-1166. 2015
Patient safety, resident well-being and continuity of care with different resident duty schedules in the intensive care unit: a randomized trial. CMAJ. 187:321-329. 2015
Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5). BMC Pregnancy and Childbirth. 14:272. 2014
Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial. Current Controlled Trials in Cardiovascular Medicine Trials. 15:170. 2014
Underestimation of Uncertainties in Health Utilities Derived from Mapping Algorithms Involving Health-Related Quality-of-Life Measures. Medical Decision Making. 34:863-872. 2014
Effect of Oximetry on Hospitalization in Bronchiolitis. JAMA - Journal of the American Medical Association. 312:712-712. 2014
Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A. Journal of General Internal Medicine. 29:767-773. 2014
The impact of pedestrian countdown signals on pedestrian-motor vehicle collisions: a reanalysis of data from a quasi-experimental study. Injury Prevention. 20:155-158. 2014
Value of information methods for assessing a new diagnostic test. Statistics in Medicine. 33:1801-1815. 2014
More Evidence That Unnecessary Antenatal Treatments Cause Harm–Reply. Archives of Pediatrics and Adolescent Medicine. 168:389-389. 2014
Maternal and infant predictors of attendance at Neonatal Follow-Up programmes. Child: Care, Health and Development Ambulatory Child Health. 40:250-258. 2014
Randomized Trial of Planned Cesarean or Vaginal Delivery for Twin Pregnancy. Obstetrical and Gynecological Survey. 69:61-62. 2014
Preventive Angioplasty in Myocardial Infarction. New England Journal of Medicine. 370:280-283. 2014
Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study. Archives of Pediatrics and Adolescent Medicine. 167:1102-1110. 2013
Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries. CMAJ. 185:E731-E738. 2013
A Randomized Trial of Planned Cesarean or Vaginal Delivery for Twin Pregnancy. New England Journal of Medicine. 369:1295-1305. 2013
An Improved Method on Wilcoxon Rank Sum Test for Gene Selection from Microarray Experiments. Communications in Statistics Part B: Simulation and Computation. 42:1563-1577. 2013
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 31:393-401. 2013
A FLEXIBLE NONPARAMETRIC APPROACH TO FIND CANDIDATE GENES ASSOCIATED WITH DISEASE IN MICROARRAY EXPERIMENTS. Journal of Bioinformatics and Computational Biology. 11:1250021-1250021. 2013
Effect of behavioural-educational intervention on sleep for primiparous women and their infants in early postpartum: multisite randomised controlled trial. British Medical Journal BMJ (Clinical research ed.). 346:f1164-f1164. 2013
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods. Clinical Trials. 10:54-62. 2013
Bias-corrected estimator for intraclass correlation coefficient in the balanced one-way random effects model. BMC Medical Research Methodology. 12:126. 2012
ACCOUNTING FOR BETWEEN-STUDY VARIATION IN INCREMENTAL NET BENEFIT IN VALUE OF INFORMATION METHODOLOGY. Health Economics. 21:1183-1195. 2012
Haemophilia prophylaxis: how can we justify the costs?. Haemophilia. 18:680-684. 2012
A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 30:697-712. 2012
Value of information methods for planning and analyzing clinical studies optimize decision making and research planning. Journal of Clinical Epidemiology. 65:870-876. 2012
Value of Information and Pricing New Healthcare Interventions. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 30:447-459. 2012
Effect of Antenatal Corticosteroids on Fetal Growth and Gestational Age at Birth. Obstetrics and Gynecology. 119:917-923. 2012
Transition to Neonatal Follow-up Programs. Journal of Perinatal and Neonatal Nursing. 26:90-98. 2012
Rapid versus standard intravenous rehydration in paediatric gastroenteritis: pragmatic blinded randomised clinical trial. British Medical Journal BMJ (Clinical research ed.). 343:d6976-d6976. 2011
Sample Size Determination for Cost-Effectiveness Trials. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 29:933-949. 2011
Maternal Side-Effects After Multiple Courses of Antenatal Corticosteroids (MACS): The Three- Month Follow-Up of Women in the Randomized Controlled Trial of MACS for Preterm Birth Study. Journal of Obstetrics and Gynaecology Canada. 33:909-921. 2011
The Early External Cephalic Version 2 Trial: An International Multicenter Randomized Controlled Trial of Timing of External Cephalic Version for Breech Pregnancies. Obstetrical and Gynecological Survey. 66:469-470. 2011
Presenting Evidence and Summary Measures to Best Inform Societal Decisions When Comparing Multiple Strategies. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 29:563-577. 2011
A Splint Was Not Inferior to a Cast for Distal Radial Fracture in Children. Journal of Bone and Joint Surgery - Series A. 93:970-970. 2011
Intention-to-treat and per-protocol analysis. CMAJ. 183:696-696. 2011
Cost-effectiveness analysis of cast versus splint in children with acceptably angulated wrist fractures. International Journal of Technology Assessment in Health Care. 27:101-107. 2011
The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG: An International Journal of Obstetrics and Gynaecology. 118:564-577. 2011
Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study: 2-Year Outcomes. Obstetrical and Gynecological Survey. 66:128-129. 2011
Survival distributions impact the power of randomized placebo-phase design and parallel groups randomized clinical trials. Journal of Clinical Epidemiology. 64:286-292. 2011
Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 29:87-96. 2011
Marginal Models for Censored Longitudinal Cost Data: Appropriate Working Variance Matrices in Inverse-Probability-Weighted GEEs Can Improve Precision. International Journal of Biostatistics. 7:1-27. 2011
Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes (1). Revista Chilena de Obstetricia y Ginecologia. 76:58-60. 2011
Clinical inertia in patients with T2DM requiring insulin in family practice.. Canadian Family Physician. 56:e418-e424. 2010
Response times follow lognormal or gamma distribution in arthritis patients. Journal of Clinical Epidemiology. 63:1363-1369. 2010
Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study: 2-Year Outcomes. Pediatrics. 126:e1045-e1055. 2010
Cast versus splint in children with minimally angulated fractures of the distal radius: a randomized controlled trial. CMAJ. 182:1507-1512. 2010
The Value of Value of Information. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 28:699-709. 2010
Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome. Value in Health. 13:411-417. 2010
Can Montelukast Shorten Prednisolone Therapy in Children with Mild to Moderate Acute Asthma? A Randomized Controlled Trial. Journal of Pediatrics. 155:795-800. 2009
School Playground Surfacing and Arm Fractures in Children: A Cluster Randomized Trial Comparing Sand to Wood Chip Surfaces. PLoS Medicine. 6:e1000195-e1000195. 2009
Indirect comparison: relative risk fallacies and odds solution. Journal of Clinical Epidemiology. 62:1031-1036. 2009
A flexible approximate likelihood ratio test for detecting differential expression in microarray data. Computational Statistics and Data Analysis. 53:3685-3695. 2009
Multiple Courses of Antenatal Corticosteroids for Preterm Birth (MACS): A Randomized Controlled Trial. Obstetrical and Gynecological Survey. 64:288-289. 2009
Antenatal corticosteroids to prevent preterm birth – Authors' reply. The Lancet. 373:894-894. 2009
Globally optimal trial design for local decision making. Health Economics. 18:203-216. 2009
Optimal clinical trial design using value of information methods with imperfect implementation. Health Economics. 19:n/a-n/a. 2009
Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. The Lancet. 372:2143-2151. 2008
Optimal sample size determinations from an industry perspective based on the expected value of information. Clinical Trials. 5:587-594. 2008
Pediatric oncology sedation trial (POST): A double-blind randomized study. Pediatric Blood and Cancer Medical and Pediatric Oncology. 51:634-638. 2008
Effect on birth outcomes of a formalised approach to care in hospital labour assessment units: international, randomised controlled trial. British Medical Journal BMJ (Clinical research ed.). 337:a1021-a1021. 2008
Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods. Clinical Trials. 5:289-300. 2008
Cost‐effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate. Health Economics. 17:777-791. 2008
The Option Value of Delay in Health Technology Assessment. Medical Decision Making. 28:300-305. 2008
Time and Expected Value of Sample Information Wait for No Patient. Value in Health. 11:522-526. 2008
Health Technology Assessment in the Cost-Disutility Plane. Medical Decision Making. 28:172-181. 2008
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group. Haemophilia. 0:071115150757005-???. 2008
Approximate MLEs of the parameters of location-scale models under type II censoring. Statistics. 41:385-394. 2007
Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data. Statistics in Medicine. 26:3274-3299. 2007
A Randomized, Controlled Trial of a Removable Brace Versus Casting in Children With Low-Risk Ankle Fractures. Pediatrics. 119:e1256-e1263. 2007
Clinical decision making and the expected value of information. Clinical Trials. 4:279-285. 2007
The Control of Hypertension In Pregnancy Study pilot trial. BJOG: An International Journal of Obstetrics and Gynaecology. 114:770-e20. 2007
The effect of pharmacist education on asthma treatment plans for simulated patients. Pharmacy World and Science. 29:228-239. 2007
Factors Associated with Maternal Morbidity in the Term Breech Trial. Journal of Obstetrics and Gynaecology Canada. 29:324-330. 2007
Expected value of information and decision making in HTA. Health Economics. 16:195-209. 2007
Women's Views of Their Experiences in the CHIPS (Control of Hypertension in Pregnancy Study) Pilot Trial. Hypertension in Pregnancy Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy. 26:371-387. 2007
A Behavioral-Educational Intervention to Promote Maternal and Infant Sleep: A Pilot Randomized, Controlled Trial. Sleep. 29:1609-1615. 2006
Health Status Measurements at Diagnosis As Predictors of Survival Among Adults With Brain Tumors. Journal of Clinical Oncology. 24:3636-3643. 2006
Statistical analysis of cost–effectiveness data from randomized clinical trials. Expert Review of Pharmacoeconomics and Outcomes Research. 6:337-346. 2006
The costs of planned cesarean versus planned vaginal birth in the Term Breech Trial. CMAJ. 174:1109-1113. 2006
Correction. Statistics in Medicine. 25:720-720. 2006
???Lost in Translation???. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 24:1101-1119. 2006
Economic Evaluation of Rivastigmine in Patients with Parkinson??s Disease Dementia. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 24:93-106. 2006
Randomized Controlled Trial of Hands-and-Knees Positioning for Occipitoposterior Position in Labor. Birth. 32:243-251. 2005
Similar maternal outcomes at 2 years after planned cesarean section or planned vaginal birth for breech presentation at term. Evidence-based Obstetrics and Gynecology. 7:132-134. 2005
The authors' reply. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 23:853-853. 2005
Cost-effectiveness analysis for multinational clinical trials. Statistics in Medicine. 24:1965-1982. 2005
The value of information and optimal clinical trial design. Statistics in Medicine. 24:1791-1806. 2005
Incorporation of uncertainty in health economic modelling studies. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 23:529-536. 2005
The effect of safer play equipment on playground injury rates among school children. CMAJ. 172:1443-1446. 2005
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Economics. 14:327-338. 2005
Asthma in Remission. Chest. 127:845-850. 2005
Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus. American Heart Journal. 149:434-443. 2005
Mothers' Views of Their Childbirth Experiences 2 Years Mter Planned Caesarean Versus Planned Vaginal Birth for Breech Presentation at Term, in the International Randomized Term Breech Trial. Journal of Obstetrics and Gynaecology Canada. 27:224-231. 2005
Regression methods for cost-effectiveness analysis with censored data. Statistics in Medicine. 24:131-145. 2005
Planned caesarean section decreases the risk of adverse perinatal outcome due to both labour and delivery complications in the Term Breech Trial. BJOG: An International Journal of Obstetrics and Gynaecology. 111:1065-1074. 2004
Unfinished Symphony: A Tribute to the Life and Career of Bernie O'Brien (1959–2004). Medical Decision Making. 24:538-544. 2004
Helping patients decide: Use of a decision aid for breast cancer surgery. Journal of Clinical Outcomes Management. 11:546-550. 2004
Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term: The international randomized Term Breech Trial. American Journal of Obstetrics and Gynecology. 191:917-927. 2004
Outcomes of children at 2 years after planned cesarean birth versus planned vaginal birth for breech presentation at term: The international randomized Term Breech Trial. American Journal of Obstetrics and Gynecology. 191:864-871. 2004
Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery. JAMA - Journal of the American Medical Association. 292:435-435. 2004
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ. 170:1795-1801. 2004
A glossary of economic terms. European Journal of Gastroenterology and Hepatology. 16:563-565. 2004
Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp Trial. European Journal of Gastroenterology and Hepatology. 16:543-549. 2004
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Economics. 13:461-475. 2004
Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation. American Journal of Obstetrics and Gynecology. 190:755-762. 2004
Factors Affecting Academic Promotion in Obstetrics and Gynaecology in Canada. Journal of Obstetrics and Gynaecology Canada. 26:127-136. 2004
A Survey of Canadian Practitioners Regarding Diagnosis and Evaluation of the Hypertensive Disorders of Pregnancy. Hypertension in Pregnancy Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy. 23:197-209. 2004
A Survey of Canadian Practitioners Regarding the Management of the Hypertensive Disorders of Pregnancy. Hypertension in Pregnancy Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy. 23:61-74. 2004
The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Supportive Care in Cancer. 12:19-24. 2004
A Longitudinal, Population-Based, Cohort Study of Childhood Asthma Followed to Adulthood. New England Journal of Medicine. 349:1414-1422. 2003
Factors associated with adverse perinatal outcome in the Term Breech Trial. American Journal of Obstetrics and Gynecology. 189:740-745. 2003
The randomized placebo-phase design for clinical trials. Physical Therapy in Sport. 4:129-136. 2003
Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:581-587. 2003
Primary prevention programmes are not effective in preventing adolescent pregnancies - meta-analysis. Evidence-based Obstetrics and Gynecology. 5:14-15. 2003
Shared Treatment Decision Making: What Does It Mean to Physicians?. Journal of Clinical Oncology. 21:932-936. 2003
Incremental net benefit in randomized clinical trials with quality-adjusted survival. Statistics in Medicine. 22:353-362. 2003
Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis. Family Practice. 20:77-82. 2003
Review: primary prevention strategies do not improve contraceptive use or reduce pregnancies in adolescents. Evidence-Based Medicine. 8:18-18. 2003
Association between smoking during radiotherapy and prognosis in head and neck cancer: A follow-up study. Head and Neck Surgery Head and Neck. 24:1031-1037. 2002
Using inverse-weighting in cost-effectiveness analysis with censored data. Statistical Methods in Medical Research. 11:539-551. 2002
Effectiveness of Nurses as Providers of Birth Labor Support in North American HospitalsA Randomized Controlled Trial. JAMA - Journal of the American Medical Association. 288:1373-1373. 2002
Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. The Lancet. 360:901-907. 2002
II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women. Endocrine Reviews Recent Progress in Hormone Research. 23:508-516. 2002
Meta-analyses of therapies for postmenopausal osteoporosis. Endocrine Reviews Recent Progress in Hormone Research. 23:496-497. 2002
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women. Endocrine Reviews Recent Progress in Hormone Research. 23:529-539. 2002
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis. Endocrine Reviews Recent Progress in Hormone Research. 23:540-551. 2002
VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis. Endocrine Reviews Recent Progress in Hormone Research. 23:552-559. 2002
Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 162:1465-1465. 2002
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics. 11:415-430. 2002
Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. British Medical Journal BMJ (Clinical research ed.). 324:1426-1426. 2002
Outcomes at 3 Months After Planned Cesarean vs Planned Vaginal Delivery for Breech Presentation at TermThe International Randomized Term Breech Trial. JAMA - Journal of the American Medical Association. 287:1822-1822. 2002
Is there a kink in consumers' threshold value for cost-effectiveness in health care?. Health Economics. 11:175-180. 2002
On the probability of cost-effectiveness using data from randomized clinical trials. BMC Medical Research Methodology. 1:8. 2001
Cost-effectiveness analysis when the WTA is greater than the WTP. Statistics in Medicine. 20:3251-3259. 2001
Broad-spectrum antibiotics in ORACLE. The Lancet. 358:502-502. 2001
Incremental net benefit in randomized clinical trials. Statistics in Medicine. 20:1563-1574. 2001
Cost prediction models for the comparison of two groups. Health Economics. 10:363-366. 2001
The randomized placebo-phase design for clinical trials. Journal of Clinical Epidemiology. 54:550-557. 2001
Analysis, Sample Size, and Power for Estimating Incremental Net Health Benefit from Clinical Trial Data. Controlled Clinical Trials Contemporary Clinical Trials. 22:228-237. 2001
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator. Circulation. 103:1416-1421. 2001
Term breech trial.. The Lancet. 357:225. 2001
Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC??)* for Helicobacter pylori Eradication. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 19:831-843. 2001
Term breech trial. The Lancet. 357:227-228. 2001
Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. The Lancet. 356:1375-1383. 2000
Prelabor rupture of the membranes at term: expectant management at home or in hospital?. Obstetrics and Gynecology. 96:533-538. 2000
Quality of life in spina bifida: importance of parental hope. Archives of Disease in Childhood. 83:293-297. 2000
Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction.. CMAJ. 163:166-169. 2000
A phase I study of oxidized raffinose cross-linked human hemoglobin. Critical Care Medicine. 28:2283-2292. 2000
Effect of Smoking Cessation on Mortality After Myocardial Infarction. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 160:939-939. 2000
Systematic Implementation of an Advance Directive Program in Nursing Homes. JAMA - Journal of the American Medical Association. 283:1437-1437. 2000
Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?. American Heart Journal. 139:423-429. 2000
Randomized trials versus observational studies in adolescent pregnancy prevention. Journal of Clinical Epidemiology. 53:167-174. 2000
Comparison of two standardized methods of methacholine inhalation challenge in young adults. European Respiratory Journal European Respiratory Journal, Supplement. 15:181-184. 2000
Treatment outcomes for squamous intraepithelial lesions. International Journal of Gynecology and Obstetrics Journal of the International Federation of Gynaecology and Obstetrics. 68:25-33. 2000
Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 159:2298-2304. 1999
Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem (vol 5, pg 297, 1996). Health Economics. 8:559-559. 1999
Mastectomy or Lumpectomy? Helping Women Make Informed Choices. Journal of Clinical Oncology. 17:1727-1727. 1999
Predictors of cesarean delivery after prelabor rupture of membranes at term. Obstetrics and Gynecology. 93:1031-1035. 1999
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. Health Economics. 8:203-211. 1999
Health care professionals' familiarity with non-pharmacological strategies for managing cancer pain. Psycho-Oncology. 8:99-111. 1999
Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 16:679-697. 1999
Evaluation of a patient file folder to improve the dissemination of written information materials for cancer patients. Cancer. 83:1620-1625. 1998
Natural history of cervical squamous intraepithelial lesions: a meta-analysis*1. Obstetrics and Gynecology. 92:727-735. 1998
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.. Journal of Clinical Oncology. 16:2272-2279. 1998
Impact of age and cranial irradiation on radiographic skeletal pathology in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer Medical and Pediatric Oncology. 30:347-350. 1998
Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. CMAJ. 157:1519-1525. 1997
Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. TERMPROM Study Group. Term Prelabour Rupture of the Membranes.. CMAJ. 157:1519-1525. 1997
Women's Evaluations of Induction of Labor Versus Expectant Management for Prelabor Rupture of the Membranes at Term. Birth. 24:214-220. 1997
The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer. 80:1518-1524. 1997
Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: The role of induction of labor. American Journal of Obstetrics and Gynecology. 177:780-785. 1997
Evaluation of an Educational Program to Prevent Adolescent Pregnancy. Health Education and Behavior. 24:300-312. 1997
Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 1:266-267. 1997
Benefit-risk ratios in the assessment of the clinical evidence of a new therapy. Controlled Clinical Trials Contemporary Clinical Trials. 18:121-130. 1997
Development of a health-related quality of life instrument for use in children with spina bifida.. Quality of Life Research. 6:0-0. 1997
A Controlled Trial of Nurse Practitioners in Neonatal Intensive Care. Pediatrics. 98:1143-1148. 1996
Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update. Journal of the National Cancer Institute. 88:1659-1664. 1996
Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.. Journal of the National Cancer Institute. 88:1659-1664. 1996
Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio. Journal of Laboratory and Clinical Medicine Translational Research. 128:214-217. 1996
Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem. Health Economics. 5:297-305. 1996
A randomised trial of two information packages distributed to new cancer patients before their initial appointment at a regional cancer centre. British Journal of Cancer. 73:1588-1593. 1996
Design Considerations in Crossover Trials with a Single Interim Analysis and Serial Patient Entry. Biometrics. 52:732-732. 1996
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 156:851-856. 1996
Induction of Labor Compared with Expectant Management for Prelabor Rupture of the Membranes at Term. New England Journal of Medicine. 334:1005-1010. 1996
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 334:677-681. 1996
Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group.. Canadian Journal of Ophthalmology. 31:11-17. 1996
Comparison of the prognostic significance of the Shimada classification and N-myc copy number in neuroblastoma. International Journal of Oncology. 8:343-347. 1996
Induction of labor versus expectant management: does it matter?. American Journal of Obstetrics and Gynecology. 173:352-353. 1995
The prognosis for live birth among untreated infertile couples. FERTILITY AND STERILITY. 64:22-28. 1995
DETERMINANTS IN CANADIAN HEALTH-CARE WORKERS OF THE DECISION TO WITHDRAW LIFE-SUPPORT FROM THE CRITICALLY ILL. JAMA - Journal of the American Medical Association. 273:703-708. 1995
Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. JAMA - Journal of the American Medical Association. 273:703-708. 1995
Comment on the effectiveness of induction of labor for postterm pregnancy. American Journal of Obstetrics and Gynecology. 172:240-241. 1995
Quality of life after myocardial infarction. Journal of Clinical Epidemiology. 47:1287-1296. 1994
Argon Green vs Krypton Red Laser Photocoagulation for Extrafoveal Choroidal Neovascularization. Archives of Ophthalmology. 112:1166-1166. 1994
Risk factors for gastrointestinal bleeding in critically ill patients. Gastroenterology Nursing. 17:89-89. 1994
Survey of family physicians: what is their role in cancer patient care?. The Canadian journal of oncology. 4:285-290. 1994
Power function arguments in support of an alternative approach for analyzing management trials. Controlled Clinical Trials Contemporary Clinical Trials. 15:211-219. 1994
Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.. Thorax. 49:479-484. 1994
Performances of 27 MEDLINE systems tested by searches with clinical questions. Journal of the American Medical Informatics Association : JAMIA. 1:285-295. 1994
Risk Factors for Gastrointestinal Bleeding in Critically Ill Patients. New England Journal of Medicine. 330:377-381. 1994
In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care. Medical Care. 32:150-163. 1994
Determining a minimal important change in a disease-specific quality of life questionnaire. Journal of Clinical Epidemiology. 47:81-87. 1994
Occupation and the clinical characteristics of infertile couples.. Canadian Journal of Public Health. 85:28-32. 1994
Measuring quality of life in the frail elderly. Journal of Clinical Epidemiology. 46:1433-1444. 1993
A measurement process for evaluating clinical teachers in internal medicine.. CMAJ. 149:1097-1102. 1993
Occupation and the follow-up of infertile couples**Funded in part by the National Health Research and Development Program, National Department of Health and Welfare, Ottawa, Ontario, Canada (Project number 6606-2628-44) and in part by contract 91-R-515 from the Royal Commission on New Reproductive Technology, Ottawa, Ontario, Canada.††The views expressed are those of the authors and not necessarily those of the National Department of Health and Welfare or the Royal Commission.. FERTILITY AND STERILITY. 60:477-485. 1993
Effect of a new nootropic agent, CGS 5649B, on cognition, function, and behavior in dementia. Journal of General Internal Medicine. 8:444-447. 1993
The effect of increasing doses of β-agonists on airflow in patients with chronic airflow limitation. Respiratory Medicine. 87:433-438. 1993
SHOULD UNPUBLISHED DATA BE INCLUDED IN METAANALYSES - CURRENT CONVICTIONS AND CONTROVERSIES. JAMA - Journal of the American Medical Association. 269:2749-2753. 1993
Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA - Journal of the American Medical Association. 269:2749-2753. 1993
Interviewer versus self-administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthma. Journal of Clinical Epidemiology. 46:529-534. 1993
A program to enhance clinical use of MEDLINE. A randomized controlled trial.. The Online journal of current clinical trials. Doc No 56:[4005-words. 1993
A Diagnostic and Therapeutic N-of-1 Randomized Trial. Canadian Journal of Psychiatry. 38:251-254. 1993
Toronto clinic's new approach.. CMAJ. 148:1270-1272. 1993
ARGON GREEN VS KRYPTON RED LASER PHOTOCOAGULATION OF EXTRAFOVEAL CHOROIDAL NEOVASCULAR LESIONS - ONE-YEAR RESULTS IN AGE-RELATED MACULAR DEGENERATION. Archives of Ophthalmology. 111:181-185. 1993
PHYSICIANS PERCEPTIONS OF LABORATORY COSTS IN THE INTENSIVE-CARE UNIT. Clinical and Investigative Medicine. 15:476-481. 1992
CLINICAL-TRIALS - WHERE DO WE GO FROM HERE - REPLY. Canadian Journal of Ophthalmology. 27:271-271. 1992
Laboratory diagnosis of iron-deficiency Anemia: An overview. Journal of General Internal Medicine. 7:423-423. 1992
Induction of Labor as Compared with Serial Antenatal Monitoring in Post-Term Pregnancy. New England Journal of Medicine. 326:1587-1592. 1992
Prognostic Variables for Survival of Neonatal Foals Under Intensive Care. Journal of Veterinary Internal Medicine. 6:89-95. 1992
Serum Cortisol: A Predictor of Mortality in Sepsis?. Journal of Intensive Care Medicine. 7:84-89. 1992
Comparing in-patient classification systems: A problem of non-nested regression models. Statistics in Medicine. 11:1321-1331. 1992
Reduction in Clinical Response to Empiric Antimicrobial Therapy of Febrile Granulocytopenic Patients Receiving TMP/SMX Infection Prophylaxis. Canadian Journal of Infectious Diseases Canadian Journal of Infectious Diseases and Medical Microbiology. 3:235-239. 1992
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.. Journal of Clinical Oncology. 9:1983-1993. 1991
Factors affecting physicians' decisions on caring for an incompetent elderly patient: an international study.. CMAJ. 145:947-952. 1991
Use of Severity to Evaluate Appropriateness of Admissions and Length of Stay. Healthcare Management Forum. 4:31-34. 1991
Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis. Journal of the National Cancer Institute. 83:1169-1173. 1991
Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.. Journal of Clinical Oncology. 9:729-735. 1991
Observations on intramammary infection and somatic cell counts in cows treated with recombinant bovine somatotropin.. Canadian Journal of Veterinary Research. 55:196-198. 1991
Indirect costs of teaching in Canadian hospitals.. CMAJ. 144:149-152. 1991
A Comparison of Manual and Power-Assisted Thoracolumbar Disc Fenestration in Dogs. Veterinary Surgery. 19:323-327. 1990
Estimating the Size of Family Practice Populations. Medical Care. 26:1228-1233. 1988
RE: "SEASONAL VARIATION OF TRANSMISSION RISK OF LYME DISEASE AND HUMAN BABESIOSIS". American Journal of Epidemiology. 128:1383-1383. 1988
SEASONAL-VARIATION OF TRANSMISSION RISK OF LYME-DISEASE AND HUMAN BABESIOSIS. American Journal of Epidemiology. 128:1383-1383. 1988
The Severity of Illness Index and laboratory testing.. Canadian Journal of Public Health. 79:435-439. 1988
Argon green and krypton red laser treatment of diabetic macular edema.. Canadian Journal of Ophthalmology. 23:262-266. 1988
Home Nebulizers in Childhood Asthma. Clinical Pediatrics. 27:420-424. 1988
Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.. Journal of Clinical Oncology. 6:1254-1263. 1988
Observer variation in the pathologic diagnosis of malignant lymphoma in Canada. Cancer. 62:314-318. 1988
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.. Journal of Clinical Oncology. 6:633-641. 1988
Using the Maximum Test Statistic in the Two-Period Crossover Clinical Trial. Biometrics. 44:211-211. 1988
Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma. Gynecologic Oncology. 29:208-221. 1988
A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients. British Journal of Cancer. 57:94-99. 1988
Linear rank tests for radomazed block design. Communications in Statistics - Theory and Methods. 17:2455-2470. 1988
Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer. Annals of Internal Medicine. 107:451-451. 1987
Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.. Cancer Treatment Reports. 71:981-982. 1987
A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic test. Gynecologic Oncology. 27:269-278. 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.. Cancer Treatment Reports. 71:277-281. 1987
Using baseline measurements in the two-period crossover clinical trial. Controlled Clinical Trials Contemporary Clinical Trials. 7:282-289. 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.. Clinical and Investigative Medicine. 9:225-231. 1986
Carryover and the Two-Period Crossover Clinical Trial. Biometrics. 42:593-593. 1986
TESTING HYPOTHESES IN CLINICAL-TRIALS - EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP. Cancer Treatment Reports. 70:1133-1136. 1986
THE USE OF VP-16 PLUS CISPLATIN DURING INDUCTION CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER. Seminars in Oncology. 13:10-16. 1986
The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.. Seminars in Oncology. 13:10-16. 1986
The Negative Binomial Model and the Denominator Problem in a Rural Family Practice. Family Practice. 3:174-183. 1986
A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.. Journal of Rheumatology. 12:724-727. 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 145:1083-1088. 1985
Hypothesis testing and sample size for bivariate binomial response in the comparison of two groups. Journal of Chronic Diseases. 38:603-608. 1985
Marijuana use during pregnancy and decreased length of gestation. American Journal of Obstetrics and Gynecology. 150:23-27. 1984
Clinical trials as diagnostic tests. Controlled Clinical Trials Contemporary Clinical Trials. 5:107-113. 1984
Methodologic issues in trials of antiemetics.. Journal of Clinical Oncology. 2:484-487. 1984
Relative efficiency in survival analysis. Journal of Chronic Diseases. 36:183-192. 1983
ISCHqMIC HEART-DISEASE AND GARLIC. The Lancet. 314:104-105. 1979
Meaningful Multicollinearity Measures. Technometrics. 20:407-412. 1978
222: Personalizing twin delivery management: A secondary analysis of a randomized clinical trial comparing planned caesarean or planned vaginal delivery. American Journal of Obstetrics and Gynecology. S146-S146. 2018
224: Urinary incontinence 2 years after cesarean or vaginal birth for twin pregnancy: A multicenter randomized trial. American Journal of Obstetrics and Gynecology. S147-S147. 2018
805: Postpartum depression assessment in the Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS). American Journal of Obstetrics and Gynecology. S462-S462. 2017
MATERNAL VITAMIN D SUPPLEMENTATION DURING PREGNANCY AND LACTATION TO PROMOTE INFANT GROWTH IN DHAKA, BANGLADESH (MDIG TRIAL): A RANDOMIZED CONTROLLED TRIAL. Annales Nestle Annals of Nutrition and Metabolism. 571-571. 2017
24: Twin birth study: 2-year follow-up of the randomized trial comparing planned cesarean vs planned vaginal delivery for twin pregnancy. American Journal of Obstetrics and Gynecology. S18-S18. 2016
Cesarean versus vaginal delivery for women in spontaneous labor of twin pregnancy: A secondary analysis of the Twin Birth Study. American Journal of Obstetrics and Gynecology. S164-S164. 2016
Induction of labor versus cesarean section in twin pregnancies: A secondary analysis of the Twin Birth Study. American Journal of Obstetrics and Gynecology. S164-S165. 2016
The role of biomarkers in improving clinical trial success: A study of 1,079 oncology drugs.. Journal of Clinical Oncology. e17804-e17804. 2015
495: Preterm premature rupture of membranes and adverse neurodevelopmental outcomes at 5 years of age: a multiple courses of antenatal corticosteroids for preterm birth study secondary analysis. American Journal of Obstetrics and Gynecology. S250-S250. 2015
75: Twin birth study: incidence of caesarean delivery in induction of twin pregnancies. American Journal of Obstetrics and Gynecology. S52-S52. 2015
Maternal 3 Month Outcomes after Planned Cesarean (CS) vs Planned Vaginal Birth (VB) for Twin Pregnancies: The Twin Birth Study (TBS).. Journal of the Society for Gynecologic Investigation Reproductive Sciences. 284A-284A. 2014
578: Twin Birth Study: neonatal and maternal outcomes in induction in twin pregnancies. American Journal of Obstetrics and Gynecology. S285-S285. 2014
595: Twin Birth Study: an analysis of the predictors for a successful planned vaginal twin birth. American Journal of Obstetrics and Gynecology. S293-S293. 2014
656: Multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5): association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years of age. American Journal of Obstetrics and Gynecology. S321-S322. 2014
Underestimation of uncertainties in health utilities dervied from mapping algorithms involving health-related quality of life measures: statistical explanations and potential remedies. Value in Health. A49-A49. 2013
2: Multiple Courses of Antenatal Corticosteroids for preterm birth study: 5-year outcomes (MACS-5). American Journal of Obstetrics and Gynecology. S2-S3. 2013
7: The Twin Birth Study: a multicenter RCT of planned cesarean section (CS) and planned vaginal birth (VB) for twin pregnancies 320 to 386/7 weeks. American Journal of Obstetrics and Gynecology. S4-S5. 2013
498: Do antenatal corticosteroids reduce fetal growth or gestational age at birth? A secondary analysis from the multiple courses of antenatal corticosteroids for preterm birth study (MACS). American Journal of Obstetrics and Gynecology. S226-S226. 2012
Expected value of information of future hemophilia trials. Haemophilia. 57-57. 2010
11: Outcomes of children at two years after multiple courses of antenatal corticosteroids for threatened preterm birth: the multiple antenatal corticosteroids study (MACS). American Journal of Obstetrics and Gynecology. S8-S8. 2009
456: Multiple courses of antenatal corticosteroids for preterm birth study (MACS): results of the three month maternal post partum questionnaire. American Journal of Obstetrics and Gynecology. S173-S173. 2009
PMC60 CONSISTENTLY ESTIMATING RISK DIFFERENCE IN A JURISDICTION OF INTEREST: ODDS SOLUTION TO RELATIVE RISK FALLACIES. Value in Health. A577-A578. 2008
OM2 USINGVALUE OF INFORMATION METHODOLOGYTO DETERMINE THE SAMPLE SIZE FOR A RANDOMIZED CLINICAL TRIAL FROM AN INDUSTRY PERSPECTIVE. Value in Health. A20-A20. 2008
PM3 THEVALIDITY AND RELIABILITY OF A PARENT-CHILD DYAD APPROACHTO UTILITY AND QUALITY-OF-LIFE ASSESSMENT IN CHILDREN. Value in Health. A14-A14. 2008
Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. Pharmacoepidemiology and Drug Safety. S183-S183. 2007
28 Supportive care service needs of newly diagnosed cancer patients: Results of a population based study. Radiotherapy and Oncology. S9-S9. 2006
Pediatric Stroke Initiatives and Preliminary Studies: What Is Known and What Is Needed?. Pediatric Neurology. 439-445. 2006
PCN27 HEALTH STATUS MEASURES AS PREDICTORS OF MORTALITY AMONG ADULTS WITH BRAIN TUMORS. Value in Health. A112-A112. 2006
The Chips Pilot trial (control of hypertension in pregnancy study).. Hypertension in Pregnancy Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy. 21-21. 2006
The costs of planned cesarean versus planned vaginal birth in the term breech trial. American Journal of Obstetrics and Gynecology. S124-S124. 2005
What are the supportive care service needs of recently diagnosed cancer patients? Results of a population based study. Journal of Clinical Oncology. 753S-753S. 2005
A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.. CMAJ. 17-22. 2003
A randomized.controlled trial (RCT) to evaluate the use of misoprostol for second trimester pregnancy termination associated with fetal malformation. American Journal of Human Genetics. 563-563. 2002
Use of health services and supportive care services by women with advanced breast cancer toward the end of life: Results of a longitudinal study. Journal of Palliative Care. 209-209. 2002
The influence of continuous labor support on the choice of analgesia, ambulation and obstetric outcome. Anesthesiology. U37-U37. 2002
112 A randomized controlled trial (RCT) to evaluate the use of misoprostol for second trimester pregnancy termination associated with fetal malformation. American Journal of Obstetrics and Gynecology. S112-S112. 2001
119 Outcomes at 3 months postpartum for women enrolled in the multicentre international term breech trial of planned caesarean section and planned vaginal birth for breech presentation at term. American Journal of Obstetrics and Gynecology. S114-S114. 2001
Multiple courses of antenatal corticosteroids: A systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 1073-1080. 2001
The effect of breastfeeding on the risk of atopy and asthma: A longitudinal cohort analysis. Journal of Allergy and Clinical Immunology. S233-S233. 2001
Cost-effectiveness of the implantable cardioverter defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS). Journal of the American College of Cardiology. 152A-153A. 2000
Systematic implementation of an advance directive program in nursing homes.. Journal of the American Geriatrics Society. S29-S29. 1998
Economic evaluation of chemotherapy with Mitoxantrone plus Prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomised trial with palliative endpoints. European Journal of Cancer. OP5-OP5. 1997
A randomized comparison of a 5 mg and 10 mg loading dose for the initiation of warfarin therapy. Thrombosis and Haemostasis. O2382-O2382. 1997
Economic evaluation of Helicobacter pylori eradication in the management of duodenal ulcer. HELICOBACTER PYLORI. 384-397. 1996
ARGON GREEN VERSUS KRYPTON RED LASER PHOTOCOAGULATION - TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANES IN OCULAR HISTOPLASMOSIS (OHS) - 3-YEAR RESULTS. Investigative Ophthalmology and Visual Science. S1037-S1037. 1995
DETERMINING MINIMAL IMPORTANT CHANGE IN A DISEASE-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE. Quality of Life Research. 43-43. 1994
PREDICTION OF QUALITY OF LIFE (QL) IN SPINA BIFIDA (SB) BY PARENTAL ATTITUDES AND PHYSICAL EXAM. Pediatric Research. 265-265. 1994
Cost-effectiveness ratios in clinical trials: From deterministic to stochastic models. AMERICAN STATISTICAL ASSOCIATION 1994 PROCEEDINGS OF THE BIOPHARMACEUTICAL SECTION. 19-28. 1994
COMPARING CANADIAN HOSPITALS QUALITY OF CARE USING STRUCTURED IMPLICIT PEER-REVIEW. Clinical Research. A549-A549. 1993
INHALED BECLOMETHASONE AS 1ST LINE TREATMENT FOR MILD ASTHMA IN FAMILY-PRACTICE. American Review of Respiratory Disease. A290-A290. 1993
ARGON GREEN VERSUS KRYPTON RED LASER PHOTOCOAGULATION - TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANES IN PRESUMED OCULAR HISTOPLASMOSIS (POHS). Investigative Ophthalmology and Visual Science. 1106-1106. 1993
TRIAL OF CHEMOTHERAPY AND RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE. Clinical and Investigative Medicine. B81-B81. 1987
A COMPARISON OF BEST SUPPORTIVE CARE TO 2 REGIMENS OF COMBINATION CHEMOTHERAPY IN THE MANAGEMENT OF EXTENSIVE NON-SMALL CELL LUNG-CANCER (NSCLC) - A REPORT OF A CANADIAN MULTICENTER TRIAL. Clinical and Investigative Medicine. A124-A124. 1986
CANADIAN MULTICENTER RANDOMIZED TRIAL COMPARING STANDARD (SD) AND ALTERNATING (A) COMBINATION CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC). Clinical and Investigative Medicine. A124-A124. 1986
A VALIDATION OF SELF-REPORTED MEASURES OF NAUSEA (N) AND VOMITING (V). Clinical and Investigative Medicine. A87-A87. 1985
Relative efficiency in the analysis of survival data. Controlled Clinical Trials Contemporary Clinical Trials. 154-154. 1982
MEDICAL ADRENALECTOMY WITH AMINOGLUTETHIMIDE (AG) AND TAMOXIFEN (T) FOR METASTATIC BREAST-CANCER (MBC) - EFFECT ON RESPONSE (R) AND PITUITARY-HORMONES. Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research. Meeting. 145-145. 1982


text:
Milky Way Ediciones es una editorial española especializada en la publicación de manga. Fue fundada en 2012 y tiene su sede en Ribadedeva, Asturias.

Historia
Milky Way fue fundada en 2012 por tres socios ligados a Asturias: Enrique Fuentevilla en la dirección editorial, Carlos E. Subero como editor jefe, y Patxi Larrauri en la dirección de marketing. En un primer momento, la empresa se centró en series de manga que ya habían finalizado y que por temática no interesaban a otras editoriales, con una tirada limitada que podía reimprimirse en función de su éxito comercial. La primera obra que publicaron fue Simon Sues, de la surcoreana Myung Hee Kim, con un capital inicial de 4000 euros para editar el primer tomo.

Con el paso del tiempo, Milky Way llegó a un acuerdo con Kōdansha para editar sus colecciones en España, tales como Beastars (Paru Itagaki), Bakemonogatari (Nishio Ishin), Atelier of Witch Hat (Kamome Shirahama) y Blue Period (Tsubasa Yamaguchi). Por otro lado, ha especializado una parte del catálogo en el género Boys Love, con obras autoconclusivas y series como La balada del viento y los árboles (Keiko Takemiya) y Given (Natsuki Kizu).

Referencias

Enlaces externos
 Sitio web oficial de Milky Way Ediciones

Editoriales de historieta de España

redpajama_set_name: RedPajamaWikipedia


text:
package org.bremersee.actuator.security.authentication;

import lombok.extern.slf4j.Slf4j;
import org.bremersee.security.authentication.AbstractResourceServerAutoConfiguration;
import org.bremersee.security.authentication.AuthProperties;
import org.bremersee.security.authentication.ResourceServerAutoSecurityCondition;
import org.bremersee.security.authentication.InMemoryUserDetailsAutoConfiguration;
import org.bremersee.security.authentication.JsonPathJwtConverter;
import org.bremersee.security.authentication.PasswordFlowProperties;
import org.bremersee.security.authentication.ResourceServerAutoConfiguration;
import org.bremersee.web.CorsProperties;
import org.springframework.beans.factory.ObjectProvider;
import org.springframework.boot.actuate.autoconfigure.security.servlet.EndpointRequest;
import org.springframework.boot.actuate.info.Info;
import org.springframework.boot.autoconfigure.AutoConfigureBefore;
import org.springframework.boot.autoconfigure.condition.ConditionalOnClass;
import org.springframework.boot.autoconfigure.condition.ConditionalOnExpression;
import org.springframework.boot.autoconfigure.condition.ConditionalOnMissingBean;
import org.springframework.boot.autoconfigure.condition.ConditionalOnWebApplication;
import org.springframework.boot.autoconfigure.condition.ConditionalOnWebApplication.Type;
import org.springframework.boot.autoconfigure.security.SecurityProperties;
import org.springframework.boot.context.event.ApplicationReadyEvent;
import org.springframework.boot.context.properties.EnableConfigurationProperties;
import org.springframework.context.annotation.Bean;
import org.springframework.context.annotation.Conditional;
import org.springframework.context.annotation.Configuration;
import org.springframework.context.event.EventListener;
import org.springframework.core.env.Environment;
import org.springframework.security.config.annotation.web.builders.HttpSecurity;
import org.springframework.security.config.annotation.web.configurers.ExpressionUrlAuthorizationConfigurer;
import org.springframework.security.core.userdetails.UserDetailsService;
import org.springframework.security.crypto.password.PasswordEncoder;
import org.springframework.security.web.util.matcher.NegatedRequestMatcher;

/**
 * The resource server with actuator security auto configuration.
 *
 * @author Christian Bremer
 */
@ConditionalOnWebApplication(type = Type.SERVLET)
@Conditional({ResourceServerAutoSecurityCondition.class})
@ConditionalOnClass({
    HttpSecurity.class,
    PasswordFlowProperties.class,
    Info.class
})
@AutoConfigureBefore(ResourceServerAutoConfiguration.class)
@EnableConfigurationProperties({
    CorsProperties.class,
    SecurityProperties.class,
    AuthProperties.class})
@Configuration
@Slf4j
public class ResourceServerWithActuatorAutoConfiguration
    extends AbstractResourceServerAutoConfiguration {

  /**
   * Instantiates a new resource server with actuator security auto configuration.
   *
   * @param environment the environment
   * @param securityProperties the security properties
   * @param authProperties the auth properties
   * @param corsProperties the cors properties
   * @param jwtConverterProvider the jwt converter provider
   * @param passwordEncoderProvider the password encoder provider
   */
  public ResourceServerWithActuatorAutoConfiguration(
      Environment environment,
      SecurityProperties securityProperties,
      AuthProperties authProperties,
      CorsProperties corsProperties,
      ObjectProvider<JsonPathJwtConverter> jwtConverterProvider,
      ObjectProvider<PasswordEncoder> passwordEncoderProvider) {
    super(environment, securityProperties, authProperties, corsProperties, jwtConverterProvider,
        passwordEncoderProvider);
  }

  @EventListener(ApplicationReadyEvent.class)
  @Override
  public void init() {
    super.init();
  }

  @Override
  protected ExpressionUrlAuthorizationConfigurer<HttpSecurity>.ExpressionInterceptUrlRegistry init(
      HttpSecurity httpSecurity) throws Exception {
    return httpSecurity
        .requestMatcher(new NegatedRequestMatcher(EndpointRequest.toAnyEndpoint()))
        .authorizeRequests();
  }

  @ConditionalOnExpression("'${spring.security.oauth2.resourceserver.jwt.jwk-set-uri:}'.empty")
  @ConditionalOnMissingBean
  @Bean
  @Override
  public UserDetailsService userDetailsServiceBean() {
    return new InMemoryUserDetailsAutoConfiguration().inMemoryUserDetailsManager(
        getSecurityProperties(),
        getAuthProperties(),
        getPasswordEncoderProvider());
  }

}

redpajama_set_name: RedPajamaGithub


We're pleased to offer discounts on this medication, sponsored by Pfizer®.
Your pharmacist will require a valid prescription from the doctor at pickup.
Blink doesn't need a copy of your prescription, so you can bring it straight to the pharmacy or have your doctor call it in. If you're picking up a refill, head to the pharmacy as usual.
Blink can handle your prescription transfers - it's free & easy.
Blink Health beats traditional prescription discount options in nearly every way.
Find savings on over 15,000 medications.
You'll get a Blink Card — that's your proof of purchase. You can print it out. We'll also text it to you.
When your pharmacist asks for payment, show them your Blink Card. You'll pay nothing at the pharmacy.
Watch Blink Health's feature with Lester Holt on the NBC Nightly News.
Search for your medications and find savings on over 15,000 medications.
This medication is used to treat pain caused by nerve damage due to diabetes or shingles (herpes zoster) infection.
Read the Medication Guide provided by your pharmacist before you start taking pregabalin and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth as directed by your doctor, usually once daily after an evening meal. Swallow the tablets whole. Do not split, crush, or chew. Doing so can release all of the drug at once, increasing the risk of side effects.
The dosage is based on your medical condition and response to treatment. To reduce your risk of side effects (such as dizziness and drowsiness), your doctor may direct you to start this medication at a low dose and gradually increase your dose. Follow your doctor's instructions carefully.
Do not stop taking this medication without consulting your doctor. Some conditions may become worse when this drug is suddenly stopped. Also, you may experience symptoms such as difficulty sleeping, nausea, headache, and diarrhea. To prevent these symptoms while you are stopping treatment with this drug, your doctor may reduce your dose gradually. Report any new or worsening symptoms right away.
Though it helps many people, this medication may sometimes cause addiction. This risk may be higher if you have a substance use disorder (such as overuse of or addiction to drugs/alcohol). Take this medication exactly as prescribed to lower the risk of addiction. Ask your doctor or pharmacist for more details.
Drowsiness, dizziness, headache, dry mouth, nausea, constipation, and weight gain may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Tell your doctor right away if you have any serious side effects, including: vision changes (such as blurred vision), unusual bleeding/bruising, muscle pain/tenderness/weakness (especially with fever or unusual tiredness), swelling hands/ankles/feet.
In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
Before taking pregabalin, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: heart problems (such as heart failure), kidney disease, history of an allergic reaction which included itching/swelling of the face/lips/tongue/throat (angioedema), personal or family history of a substance use disorder (such as overuse of or addiction to drugs/alcohol).
This drug may make you dizzy or drowsy or cause blurred vision. Alcohol or marijuana (cannabis) can make you more dizzy or drowsy. Do not drive, use machinery, or do anything that needs alertness or clear vision until you can do it safely. Avoid alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis).
A product that may interact with this drug is: orlistat.
If you miss a dose and remember before bedtime, take it after a snack before bedtime. If it is the next morning when you remember, take the dose after the morning meal. If you remember after the morning, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Lab and/or medical tests (such as kidney function, platelet count) may be done while you are taking this medication. Keep all medical and lab appointments. Consult your doctor for more details.
Selected from the Licensed Solutions data included with permission and copyrighted by FDB, inc., 2014. This copyrighted material has been downloaded and Licensed data provider and is not for distribution in professional healthcare settings. This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking any drug or commencing or discontinuing any course of treatment.


text:
> **Note:** Custom Git hooks must be configured on the filesystem of the GitLab
server. Only GitLab server administrators will be able to complete these tasks.
Please explore [webhooks] and [CI] as an option if you do not
have filesystem access. For a user configurable Git hook interface, see
[Push Rules](https://docs.gitlab.com/ee/push_rules/push_rules.html),
available in GitLab Enterprise Edition.

Git natively supports hooks that are executed on different actions.
Examples of server-side git hooks include pre-receive, post-receive, and update.
See [Git SCM Server-Side Hooks][hooks] for more information about each hook type.

As of gitlab-shell version 2.2.0 (which requires GitLab 7.5+), GitLab
administrators can add custom git hooks to any GitLab project.

## Setup

Normally, Git hooks are placed in the repository or project's `hooks` directory.
GitLab creates a symlink from each project's `hooks` directory to the
gitlab-shell `hooks` directory for ease of maintenance between gitlab-shell
upgrades. As such, custom hooks are implemented a little differently. Behavior
is exactly the same once the hook is created, though.

Follow the steps below to set up a custom hook:

1. Pick a project that needs a custom Git hook.
1. On the GitLab server, navigate to the project's repository directory.
   For an installation from source the path is usually
   `/home/git/repositories/<group>/<project>.git`. For Omnibus installs the path is
   usually `/var/opt/gitlab/git-data/repositories/<group>/<project>.git`.
1. Create a new directory in this location called `custom_hooks`.
1. Inside the new `custom_hooks` directory, create a file with a name matching
   the hook type. For a pre-receive hook the file name should be `pre-receive`
   with no extension.
1. Make the hook file executable and make sure it's owned by git.
1. Write the code to make the Git hook function as expected. Hooks can be
   in any language. Ensure the 'shebang' at the top properly reflects the language
   type. For example, if the script is in Ruby the shebang will probably be
   `#!/usr/bin/env ruby`.

That's it! Assuming the hook code is properly implemented the hook will fire
as appropriate.

## Chained hooks support

> [Introduced][93] in GitLab Shell 4.1.0 and GitLab 8.15.

Hooks can be also placed in `hooks/<hook_name>.d` (global) or
`custom_hooks/<hook_name>.d` (per project) directories supporting chained
execution of the hooks.

NOTE: **Note:** `<hook_name>.d` would need to be either `pre-receive.d`,
`post-receive.d`, or `update.d` to work properly. Any other names will be ignored.

To look in a different directory for the global custom hooks (those in
`hooks/<hook_name.d>`), set `custom_hooks_dir` in gitlab-shell config. For
Omnibus installations, this can be set in `gitlab.rb`; and in source
installations, this can be set in `gitlab-shell/config.yml`.

The hooks are searched and executed in this order:

1. `gitlab-shell/hooks` directory as known to Gitaly
1. `<project>.git/hooks/<hook_name>` -  executed by `git` itself, this is `gitlab-shell/hooks/<hook_name>`
1. `<project>.git/custom_hooks/<hook_name>` - per project hook (this is already existing behavior)
1. `<project>.git/custom_hooks/<hook_name>.d/*` - per project hooks
1. `<project>.git/hooks/<hook_name>.d/*` OR `<custom_hooks_dir>/<hook_name.d>/*` - global hooks: all executable files (minus editor backup files)

Files in `.d` directories need to be executable and not match the backup file
pattern (`*~`).

The hooks of the same type are executed in order and execution stops on the
first script exiting with a non-zero value.

## Custom error messages

> [Introduced][5073] in GitLab 8.10.

If the commit is declined or an error occurs during the Git hook check,
the STDERR or STDOUT message of the hook will be present in GitLab's UI.
STDERR takes precedence over STDOUT.

![Custom message from custom Git hook](img/custom_hooks_error_msg.png)

[CI]: ../ci/README.md
[hooks]: https://git-scm.com/book/en/v2/Customizing-Git-Git-Hooks#Server-Side-Hooks
[webhooks]: ../user/project/integrations/webhooks.md
[5073]: https://gitlab.com/gitlab-org/gitlab-ce/merge_requests/5073
[93]: https://gitlab.com/gitlab-org/gitlab-shell/merge_requests/93


Ahhhh summer. A time for trips to the beach, wearing less makeup, questionable decisions, and fruity drinks. There is nothing I love more than the perfect marriage of pineapple and coconut in a pina colada, but the sad truth is that they are jam-packed with sugary calories and can give you an adult tummy-ache after two or three. Plus, they're made with rum and we all know I'm a vodka girl.
1. Cut the pineapple into large chunks or buy already-cut pineapple. Put the chunks in a container, size depending on how much vodka you want to make. I used a medium-sized, cylinder-shaped plastic container with a lid (ghetto). Glass jars are classier, obviously. Pour the vodka over it (cover all the pineapple) and let it sit out overnight (no need to refrigerate). If the container has a lid, you can place the lid on top, but don't seal completely. You can let it sit out for a couple days, but overnight at least.
2. The next day (or whenever you're ready to start boozing), you can eat the pineapple by itself as a nice, alcoholic treat. A few pieces paired nicely with the Chick-fil-a biscuit I had for breakfast on Saturday at the lake. But by midday, I was "eating the pineapple like they were potato chips" (per my friend, Allyson), which is probably why I had to take a "nap" on the pontoon boat in the middle of the afternoon. But anyway. The vodka itself is the star of the show, so make a drink with it–since it will be flavorful, you really only need to mix it with soda (0 calories!), but you can add a splash of juice if you like. We discovered Dole's Pina Colada juice this weekend, but remember–just a splash if you're trying to cut cals and sugar.
3. Lastly, be careful with this summertime elixir! Because it has been so amazingly infused, the alcohol is hard to taste, so you may find yourself guzzling drinking more than usual (just trust me on this one), which could lead to passing out early, sexting your ex, or eating three pounds of taco dip (wearing a bikini).
I actually was thinking about how to make pineapple infused with vodka the other day.. I just made vodka gummy bears (delish!) so I wanted to find something else to do.


It took them about 7 weeks to write and publish the 18 or so pages needed to fix the problem, but fix it they did, and in the right way given deadlines under Meaningful Use. ONC has removed the use of the HL7 2.5.1 implementation guide specified for public health reporting in a recent interim final rule. The rule is now "on display" and is expecte to be published in the Federal Register on or soon after Wednesday of this week.
I still owe you a review of the work being done by ISDS. That is, in my opinion, presently being implemented through an unbalanced process that is dominated by one side of the transaction (the one not having "receiving" requirements under the Incentives rule).
Having said that, at least the current rule allows implementations to proceed using the 2011 criteria, and we can all breathe a bit easier right now. You will soon be able to just simply use the HITSP C39 Specification for public health reporting without hacking it to support 2.3.1 as I had previously suggested.


text:
Juraj Beneš (ur. 2 marca 1940 w Trnavie, zm. 11 września 2004 w Bratysławie) – słowacki kompozytor, pianista.

Ukończył studia na Wyższej Szkole Sztuk Scenicznych w Bratysławie i był uczniem Jána Cikkera, który był jednym z najlepszych znanych słowackich kompozytorów. Od 1983 roku Beneš uczył na tym samym uniwersytecie.

Praca Beneša poszła za aktualnymi trendami. Był najlepszy w komponowaniu oper takich jak New Clothes Emperor, Skamenen ý (Petrified) i Hostina (Feast) i często zatrudniony był jego głos razem z niezwykłymi połączeniami instrumentu (Choir Three Women).

Linki zewnętrzne
 Juraj Beneš

Pianiści
Słowaccy instrumentaliści
Słowaccy kompozytorzy
Urodzeni w 1940
Zmarli w 2004


Preston's Avenham and miller parks are beautiful and large parks idea for taking a leisurely stroll or having a relaxing picnic. The Parks are ideally located close to the town centre and Preston's Train station.
Take a break from exploring and have a drink and a cake at the coffee shop, there is also a play area for the children to let off some steam while you relax. The riverside footpath runs along the side of the River Ribble and with grassy areas and parking nearby this is ideal for all the family.
The Park also has a Japanese rock garden constructed in the 1930's featuring a Variety of ornamental plants and a waterfall and is a must see while visiting the park.
The park has played host to a variety of top performers over the years including Katherine Jenkins, JLS, Spice Girls, Oasis and the Human League to name just a few.


text:
Selling The Agression is het derde album van 'The Aurora Project', uitgebracht in 2013 door Freia Music.
De band begon met de opnames in het voorjaar van 2012 en brachten het album 8 februari 2013 uit.

Het album beschrijft de veranderende samenleving van 1999, van de invoering van internet tot de vorming van de huidige wereldorde.

Track listing
 "Dualistic Consciousness" − 5:21
 "Turning Of The Tide" − 5:18
 "Selling The Aggression" − 6:02
 "The Oil Supremacy" − 6:55
 "The Sense Of Reality" − 6:55
 "Speeding Up Of Time" − 4:05
 "Newtopia" − 9:10

Band
 Dennis Binnekade - Zanger
 Remco van den Berg - Gitarist en achtergrondzang
 Marc Vooijs - Gitarist (overleden 20 september 2014)
 Rob Krijgsman - Bassist
 Marcel Guijt - Toetsenist
 Joris Bol - Drummer

Muziekalbum uit 2013


text:
Q: how to create a NSDictionary consisting of NSArray of NString for key and bunch of int for the value? here is the problem :
NSArray * alphabets = [NSArray arrayWithObjects:@"a",@"b",@"c",@"d",@"e",@"f",@"g",@"h",@"i",@"j",@"k",@"l",@"m",@"n",@"o",@"p",@"q",@"r",@"s",@"t",@"u",@"v",@"w",@"x",@"y",@"z",nil];
NSDictionary * alphaToNum = [NSDictionary dictionaryWithObject:alphabets forKey:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26];
//I know above line meant to not work I just brought it here as an example

how can I create a dictionary just like above which is working?

A: You can only use objects as keys or values in a NSDictionary, so you have to use NSNumber as wrapper for your integer key.
NSMutableDictionary *alphaToNum = [NSMutableDictionary dictionary];
NSArray *alphabet = [NSArray arrayWithObjects:@"a",@"b",@"c",@"d",@"e",@"f",@"g",@"h",@"i",@"j",@"k",@"l",@"m",@"n",@"o",@"p",@"q",@"r",@"s",@"t",@"u",@"v",@"w",@"x",@"y",@"z",nil];
NSInteger index = 0;

for(NSString *character in alphabet)
{
    index ++;
    [alphaToNum setObject:character forKey:[NSNumber numberWithInteger:index]];
}

redpajama_set_name: RedPajamaStackExchange


text:
Spanning the Air Gap: ICS Network Security
Though some experts advocate an air gap approach to industrial security, it can create a false sense of security and make troubleshooting more difficult.
Larry Asher and Dominic Schmitz
An air gap is a network security measure used to ensure a computer network is physically isolated in order to prevent it from establishing an external connection, specifically to the Internet. The concept is that a physical gap can prevent unauthorized access, thwarting hackers and malware. In this post, we are most interested in this as a measure of security applied to industrial control systems (ICSs).
Properly implemented and maintained, air-gapped networks do offer security and can be found among some of the most secure global institutions, such as government intelligence agencies, financial institutions and others.
Writing about industrial security, Paul Ferguson, senior threat researcher for security provider Trend Micro, advocates the air gap principle. "One issue that I've consistently tried to emphasize is that critical control systems should never, ever interact nor interconnect with Internet systems in any way, shape or form," Ferguson has written.
While the use of air-gapped networks for ICS does offer a measure of security, you will likely find that support even among respected authorities tends to be the exception.
"IT security could have ignored the OT network as it being disconnected, air gapped, proprietary and not subject to the same sort of threats and attacks in the past, but this mindset is no longer effective," wrote David J. Meltzer, chief research officer at Tripwire, another security provider. "Cooperation on a consistent security strategy across both IT and OT is essential for the future."
It is our observation that for the majority of ICS networks the implementation of an air gap largely leads to a false sense of security. Further, we believe it has the potential of not only placing false constraints on the network, it may be a contributing factor to a degraded network state compromising the overall performance of the network, and the source of hidden and/or unrecognized cost.
Considering the various pathways that can act as a conduit for intrusion and malicious intent—such as removable devices, laptops, diagnostic equipment and the like—an air-gapped network can leave one with a false sense of security. The Repository of Industrial Security Incidents (RISI) has noted the majority of incidents happen from within the ICS network. Other studies note the primary threat as malware being introduced to a system through a USB memory stick.
In this age of the Industrial Internet of Things (IIoT) and smart manufacturing, manufacturers are recognizing the benefits of a more fully integrated plant floor resulting in optimized operations and increased profits. Using an air gap for network security places a false constraint on networks, denying real-time access into manufacturing operations and thus delaying cost-saving decisions that could otherwise be made.
An isolated control network "hidden" on the plant floor could be overlooked, especially if it exists outside of the IT/OT area of responsibility. True, some would prefer it that way, but with the increased use of Ethernet on the plant floor, these forgotten networks will become degraded and problematic. A network that is flat and does not get upgraded throughout the years will start to become slow as other devices are added to the ICS. Network architectures that once handled the traffic are now becoming taxed and less efficient as ICS networks grow and see greater demands placed on them.
The inability to support remote access or external devices on an ICS network can greatly increase troubleshooting and maintenance costs. In some cases, limiting support to the "sneakernet" could increase downtime. At the same time, well-intentioned employees with a desire to resume production might be tempted to bypass network security protocols, even further compromising the system.
Creating an air gap might sound simple in theory (just unplug it), but, like many things, the actual implementation of an effective solution is much more difficult. Though we are discouraging this practice, we are not ruling out the potential effectiveness of an air gap to provide a secured network, even for an ICS. We do, however, encourage you to consider the cost, constraints and administrative burden it places on your organization. Doing so will help you to make a well informed decision and help to avoid being left with a false sense of security and the other shortcomings we have mentioned.
Next month, we will discuss the essentials of a secured industrial network, addressing aspects of the network architecture and security.
Larry Asher is director of operations and Dominic Schmitz is operational technology specialist at Bachelor Controls Inc., a certified member of the Control System Integrators Association (CSIA). For more information about Bachelor Controls, visit its profile on the Industrial Automation Exchange.
Bachelor Controls, Inc.
Control System Integrators Association (CSIA)
Network Portal Targets Interoperability
With the release of its PCH Portal, Parker Hannifin looks to address industry's ongoing need to integrate disparate networks and devices with a flexible network portal capable of communicating across protocols, standards, and vendors.
Is the Cloud Beneficial for Small and Mid-Sized Manufacturers?
Learn how manufacturers are actually using cloud computing today and how it can be leveraged for optimal application by smaller manufacturing organizations in this discussion with Brian Fenn, COO of system integration company Avanceon.
Emerson Takes on Magnolia Power Plant Project in Mississippi
Manufacturers aren't the only adopters of Industry 4.0 technologies—the utility sector has long been active in the space as well, and the Tennessee Valley Authority has recently pledged $110 million to digitally transform its power generation fleet.
Edge Computing Gets a Platform Focus
Recent announcements from Siemens and Stratus Technologies/Rockwell Automation show how edge computing is evolving into a platform for broader industrial digitalization applications.
Volkswagen Expands Cloud Project Beyond Europe
The Industrial Cloud Initiative at Volkswagen, designed to streamline data gathering and analysis as well as best practice adoption, is expanding to one U.S. plant and two in Mexico.
Check out The Cobot Spot from Universal Robots
Looking for automation solutions for packaging and palletizing? This is your destination for all things cobot. Whether it's webinars, video case studies or product information, you'll find it all in this one spot.
A New Kind of Connected Factory
As a pandemic forces social distancing, manufacturers are using technology to stay connected, creating a new vision for how data is aggregated, shared, and acted upon to unite factories and people.
Stephanie Neil
Moving to a More "Open" Environment
Discover how edge computing and open source software are important contributions to the successful implementation of IoT at your company.
Dick Slansky
Dec 1st, 2020
Connecting Sensors to the Cloud
The "last mile" connection of lower-level plant floor devices to the cloud is the focus of a new partnership between ifm and CloudRail.
Pre-Project Consulting Role for SI
Discover how incorporating a System Integrator at the beginning of your automation integration process can have a vital impact on the success of your overall project.
Duane Grob
The Connected Plant in the Digital World
While most in the manufacturing industry understand the implications of a connected plant, less know why or how this shift should occur. Find out three actions your company should consider before making the transformation.
The Challenge of Manufacturing Data Management
What happens when automation and plant IT teams get past their differences and work together effectively? A chance for the company to outperform the competition and make progress on Industry 4.0 projects.
Julie Fraser
Microsoft Extends Industrial Focus with Expanded Rockwell Automation Partnership
The aim of this new partnership is to connect development, operations, and maintenance teams through a "singular, trusted data environment" that extends from the edge to the cloud.
Digital Transformation in Manufacturing: Small Steps or One Giant Leap?
How taking three practical steps can generate short-term wins and achieve long-term success with Industrial Internet of Things technologies.
Zach Gustafson
Beginning the Digital Transformation Process
In this episode, we connect with Bill Pollock, CEO of Optimation, to explore how industrial companies are moving forward with their digital transformations. We discuss how to assess current operations, avoid common mistakes, and apply metrics.
Artificial Intelligence in Manufacturing
As more artificial intelligence-enabled products come into market, learn about the roadblocks these products are creating and how OEMs are working through them.
Florian Güldner
Understanding Virtualization for Industrial Automation
Grasping the concept of virtualization is an important factor in developing and deploying Industrial Internet of Things applications because of how virtualization enables scale, security, and portability, as well as speed and agility factors.
Intel Targets Digital Transformation with New Processors
Highlighting the promise of the Industrial Internet of Things and Time-Sensitive Networking, Intel releases multiple new processors delivering artificial intelligence, security, functional safety, and real-time communication capabilities.
Oct 1st, 2020
Accessing the Far Regions of Automation
As more organizations invest in remote access capabilities, providing information technology support can come with a few issues when it comes to troubleshooting and connectivity.
Brian Fenn
More in IIoT
Guidance on Industrial Blockchain Use
The Industrial Internet Consortium releases a white paper that provides direction on the use of blockchain applications for Industrial Internet of Things applications.
Technology Matters: IIoT Missteps, Cybersecurity Readiness, and Volkswagen's Industrial Cloud
Automation World explores a new report that outlines key steps around the Industrial Internet of Things many manufacturers overlook, how to assess your cybersecurity readiness, and why Volkswagen created an automation app store for its plants.
Banner Engineering Launches Business Unit
Banner Engineering launches new business unit, SmartSolutions, featuring easy-to install, integrated, and customizable IIoT kits of its sensors, wireless solutions, and LED lighting.
Banner Engineering Corp.
Volkswagen Looks to the Cloud for Productivity Gains
The open Industrial Cloud initiative at Volkswagen is expanding to include multiple new manufacturing and technology partners in an app store-like approach to boost Volkswagen's production operations.
Sep 2nd, 2020
Time-Sensitive Networking: Five Ways the IEEE Standards Will Advance Industry 4.0
Understanding why the data accessibility provided by Time-Sensitive Networking will help industrial organizations achieve the promise of Industry 4.0.
Jordon Woods
Compressed Air Measurement Helps Reduce Energy Use
Installing Festo's E2M energy efficiency modules helped medical device and pharmaceutical manufacturers tackle their environmental footprint, not only saving money but using the data to provide predictive maintenance as well.
Aaron Hand
The Smart Businesses Guide to Intelligence at the Edge and IIOT
Technology that enables business continuity and agility in every condition is essential today and into the future.
Renea Sloan
Designing Fault-Tolerant IIoT Systems
Combine MQTT with industrial broker software and Sparkplug B compatible devices to create a foundation for mission-critical IT/OT systems.
Industry 4.0: Thriving Through Transformation
As the global pandemic continues, manufacturers should look towards Industry 4.0 technology as a way to operate at optimal performance and keep its workforce safe and healthy.
Chad Geretz
Digital Transformation for Small and Medium Manufacturers
Small and medium manufacturers have largely been hesitant to make the transition to a smart manufacturing system due to concerns over the cost and time investment. However, those hesitations may not actually be true when the implementation is done right.
Dr. Ananth Seshan
Next-Generation Andon
The 'Christmas-tree' stack lights of yore are all grown up. Thanks to the rise of smart communication technologies, today's Andon systems are IIoT- and intelligent-messaging-enabled indicators of real-time shop-floor KPI performance.
Lauren Gibbons Paul
Conducting Virtual FATs: Best Practices
Brand-new guidance from PMMI's OpX Leadership Network addresses the critical need for virtual factory acceptance testing during the COVID-19 pandemic.

redpajama_set_name: RedPajamaCommonCrawl


Vanilla, lavender, roses, etc. The choices for scented candles are infinite. There is a scent for every single person to fall in love with.
A company from Australia has made a set of new scented candles – with unusual scents.
So how about chatting a little at home on the couch and lighting a candle that smells like beer, or even cheeseburgers?
The scent of a McDonald's cheeseburger or an ice-cold beer would probably get most of us drooling. A cold beer is one of the best liquids you can drink after a long day at work. Now, for the first time, you can have those delicious fragrances present at all times, writes the British site The Mirror.
Gray Lines, an Australian online store, is selling the mentioned beer and cheeseburger scented candles among other products.
The scented candles, especially the one with cheeseburger smell, are immensely popular and sell out quickly after every time they restock.
A scented candle costs around $20 and burns for an impressive 30 hours.
Customers have showered with praise the amazing candles.
"Yes, oh man this is probably the best gift ever… does it come with the matching fries scent too?" Writes a user.
"When cheeseburgers are life. If I can't eat them, might as well smell them" Writes another happy candle owner.
But Gray Lines also has more unusual scents in its range.
If cheeseburgers or beers are not your types of scent, you can check out the numerous options at Gray Lines.
They have, among other things, candles with the scent of garlic bread that will make your whole place smell like a bakery.
Such a treat! – who would say no to the scent of a cheeseburger, beer or garlic bread at home?
Now hit that SHARE button so your friends can see this too!


On Friday, which is generally accepted in public relations circles as the best day of the week to release controversial news, the United States Copyright Royalty Board (image to the right) announced new royalty rates for webcasts, effective from 2006 to 2010.
The board ignored the arguments of the International Webcasting Association and other webcasters, and apparently simply endorsed the proposal of the RIAA-associated SoundExchange royalty organization, which represents the major and some indie labels.
to 1.2 cents per listener-hour range. That math suggests that the royalty rate decision — for the performance alone, not even including composers' royalties! — is in the in the ballpark of 100% or more of total revenues."
The situation looks grim for webcasters large and small. Even tiny siteswould owe the minimum of $500 per channelper year, which could also have implicationsfor webcasters who provide customized radio stations, since the CRB does not define whether those would each constitute a "channel" (whatever that is). Webcasters have a 15-day period to ask the CRB to rehear arguments.


text:
George Jackson (Indianola, 12 maart 1945 – Ridgeland, 14 april 2013) was een Amerikaans zanger in het genre southern soul en songwriter in de muziekstijlen soul, rock en rhythm & blues.

Biografie
Jackson was nog een tiener toen hij zijn eerste liedjes schreef. Ike Turner nam hem in 1963 mee naar de succesvolle studio van Cosimo Matassa in New Orleans, hij was toen ongeveer achttien jaar oud. Hier werden zijn eerste liedjes opgenomen. Ook nam hij in die jaren zijn eerste singles op.

Hij schreef in de jaren zestig ook samen met Dan Greer voor Goldwax Records in Memphis. Met betrekking tot die tijd werd in 2015 nog een album samengesteld met werk dat ze daar schreven, getiteld George Jackson and Dan Greer at Goldwax. Ook vormde hij met hem het duo Jackson & Greer.

Vervolgens vertrok hij naar de muziekstad Muscle Shoals. Hij schreef eerst bij de Fame Studios en later bij de concurrent Muscle Shoals Sound Studios. Bij deze twee studio's behaalde hij als songwriter zijn eerste successen. De laatste studio werd opgekocht door Malaco Records die Jackson vervolgens contracteerde als vaste songwriter.

In 1970 hadden The Osmonds een nummer 1-hit met zijn pennenvrucht One bad apple. Ook had Bob Seger in 1979 een hit met een lied dat hij schreef, samen met Thomas Jones III, namelijk Old time rock and roll dat in de top 40 belandde. Dit lied werd later ook in veel films en televisieshows gebruikt. Daarnaast waren er tal van andere bekende artiesten die zijn werk op de plaat zetten, zoals Z. Z. Hill, Ike & Tina Turner, James Brown, Clarence Carter en Wilson Pickett. Al met al schreef hij honderden liedjes in de stijlen soul, rock en rhythm & blues.

Hij bracht zelf weliswar een groot aantal singles uit. Maar terwijl veel andere artiesten hits hadden met zijn werk, behaalde alleen zijn single That's how much you mean to me (1970) een hitnotering, namelijk op nr. 48 van de Billboard Hot R&B.

Discografie
Hieronder volgt een selectie van werk dat hij zelf uitbracht.

Albums
 1991: Heart to heart collect
 2002: George Jackson in Muscle Shoals
 2006: What would your mama say
 2009: In Memphis 1972-77
 2010: All because of your love
 2011: Don't count me out: The Fame recordings (Volume 1)
 2012: Let the best man win: The Fame recordings (Volume 2)
 2013: Old friend: The Fame recordings (Volume 3)
 2013: George Jackson and Dan Greer at Goldwax

Singles
 1965: Blinkity blink
 1965: Rufus come and get your dog
 1967: I'm gonna wait
 1968: I just got to have you
 1969: Find 'em, fool 'em and forget 'em
 1969: My desires are getting the best of me
 1970: That's how much you mean to me, nr. 48 in de Billboard Hot R&B
 1971: I found what I wanted
 1972: Aretha, sing one for me
 1973: Let them know you care
 1973: We've only just begun
 1974: How can I get next to you?
 1974: Smoking and drinking
 1974: How can I get next to you? (7", promo)
 1975: Things are getting better
 1976: Talking about the love I have for you
 1979: Fast young lady
 1984: Times are tough
 1985: Sam, we'll never forget you, met Louis Williams
 2008: The hytones
 2012: Victim of a foolish heart
 ?: Struggling lady

Amerikaans soulzanger
Amerikaans tekstdichter
Amerikaans componist
Amerikaans singer-songwriter


In an interview with CTV, the Russian ambassador to Canada took a hard line on NATO, alleged Russian hacks during the U.S. election, and praised Trump's victory.
In a wide-ranging interview with CTV, one of Canada's largest television networks, Russian ambassador to Canada Alexander Darchiev took a hard line on NATO's presence in eastern Europe.
NATO says it has built up its forces along Russia's borders with Eastern Europe because of "Russian aggression," highlighted by Russia's annexation of Crimea in 2014.
"No. We have a definite answer on that," Darchiev said when asked if Russia was behind the hacks, which saw the documents made public by Wikileaks.
There is strong evidence the Russian government is tied to the hacks.


Stunning home that has been meticulously cared for. Enjoy relaxing mornings in the sun room with a wall of windows to the spacious fenced yard with stamped concrete patio. Gleaming hardwood floors throughout. Open floor plan with views to the kitchen, tons of cabinets, corian counters, kitchen island & kitchen table space. Large bedrooms with 3rd room being used as an office.(no closet).